This job has expired

You will need to login before you can apply for a job.

Executive Assistant

Employer
Vaxcyte, Inc.
Location
San Carlos, California
Start date
Jul 21, 2022

View more

Discipline
Administration, Clerical
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay
You need to sign in or create an account to save a job.

Job Details

Company Profile:

Vaxcyte, Inc. (Nasdaq: PCVX) is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease (IPD). The Company is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and our exclusively licensed XpressCFTM cell-free protein synthesis platform. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. The Company is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked. For more information, visit www.vaxcyte.com.
 
Vaxcyte, headquartered in San Carlos, CA, went public in June 2020 and currently has a team of approximately 100 employees and anticipates continued, significant growth. On January 6, 2022, Vaxcyte announced that the U.S. Food and Drug Administration (FDA) had cleared the Investigational New Drug (IND) application for VAX-24, its lead vaccine candidate. The Company initiated the VAX-24 Phase 1/2 clinical proof-of-concept study in adults in the first quarter of 2022 and expects to announce Phase 2 topline immunogenicity, safety, and tolerability results by the end of the year. VAX-24 was designed to prevent IPD, which can be most serious for infants, young children, older adults and those with immune deficiencies or certain chronic health conditions. Given the global impact of pneumococcal disease remains significant, the public health community continues to advocate for vaccines that can offer broader protection to prevent IPD. Vaxcyte’s PCV franchise, consisting of VAX-24 and VAX-XP, is designed specifically to address this need and has the potential to deliver the broadest protection for this very serious disease.

Summary:

Vaxcyte is seeking a dynamic Executive Assistant to provide support to the Senior Vice President of Process Development & Manufacturing. This role will provide as a strategic partner to hold everything together, from calendaring and travel, to team support, and prioritizing work flow. We are looking for an EA who has a natural passion for learning, enjoys taking on new tasks and projects, and who excels in an energetic, fast paced environment. Must possess a high degree of poise and professionalism. Strong communication skills are essential. Candidate must be proficient with various software programs, including MS PowerPoint, Word, Excel and Outlook.

Essential Functions:
    • Be the executive's right hand by attending important meetings, taking notes, being an active participant and knowledgeable resource, while ensuring executive preparation and effectiveness. 
    • Keep a pulse on daily agendas and immerse yourself in their priorities.
    • Calendar management and understand the context of the business to effectively plan their schedules.
    • Work closely with the HR an administrative team.
    • Develop an understanding of the team and field requests from all contacts, making a point to be available and approachable. 
    • Demonstrate composure and flexibility, regardless of competing priorities. 
    • Find new and efficient ways to create work processes to help maximize your executives' time, including weekly reporting, goal-tracking, and team meetings.
    • Having a science and biotech background is a plus.

Requirements:
    • 4 + years’ experience in an administrative role supporting an executive.
    • Bachelor’s Degree preferred.
    • Advanced knowledge of MS Office including Outlook, Word, Excel and PowerPoint; 
    • Strong interpersonal skills, with excellent written and verbal communication skills.
    • Ability to effectively communicate with people at all levels and from various backgrounds.
    • Versatility, flexibility, and a willingness to work within constantly changing priorities with passion and enthusiasm.
    • Commitment to excellence and high standards with attention to detail.
    • Strong organizational, problem-solving, and analytical skills; able to manage priorities and workflow.
    • All Vaxcyte employees require vaccination against COVID-19.

Reports to: SVP PD, AD and CMC

Location: San Carlos, CA

Compensation: 
The compensation package will be competitive and includes comprehensive benefits and an equity component.


Vaxcyte, Inc.
825 Industrial Rd.
Suite 300, San Carlos, CA 94070

Company

Vaxcyte, Inc. (Nasdaq: PCVX) is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent some of the most common and deadly infectious diseases worldwide. Our exclusively licensed cell-free protein synthesis platform and our proprietary know how enable us to design and produce optimized protein carriers and antigens, the critical building blocks of vaccines, in ways that we believe conventional vaccine technologies cannot. Our lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease. Our pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.

Find Us
Website
Phone
(650) 837-0111
Location
353 Hatch Drive
Foster City, CA 94404
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert